Patent Yard Sign in
Expired Canadian patentCanada

Methods of inhibiting phagocytosis

CA 2223402 C · Owner: Park, Jong-Gu · Inventors: Schreiber, Alan D.; Park, Jong-Gu

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention relates, in general to methods of treating diseases , resulting from interactions between immune complexes and Fc receptors. In particular, the present invention relates to methods of modulating the clearance of antibody-coated cells from the circulation by inhibiting phagocytosis and to methods of modulating the interaction of immune complexes with tissue Fc receptors. Further, the invention relates to methods of modulating the activation of immunological processes mediate by Fc receptor activation resulting from antibody-antigen/receptor interaction.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed June 7, 1996 and granted July 31, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 7, 2016.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 7, 2018.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 7, 1996
GrantedJuly 31, 2012
Term endedJune 7, 2016
Patent numberCA 2223402 C
Classification (IPC)C12N15/12 +2 more

Timeline

Timeline From CIPO dates

1997199920012003200520072009201120132015Application filedJune 7, 1996Patent grantedJuly 31, 2012Term endedJune 7, 2016

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.